Eikon Therapeutics, Inc. · NASDAQ:EIKN
Eikon Therapeutics, Inc. shareholders
As of Jun 30, 2026, 72 institutions reported holding Eikon Therapeutics, Inc., 48.9% of its shares. Largest: Fidelity, BlackRock and T. Rowe Price. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eikon Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 4.99M | 9.2% | +1.16M | Aug 13, 2026 |
| BlackRock | 4.28M | 7.9% | +962K | Aug 7, 2026 |
| T. Rowe Price | 2.6M | 4.8% | +402K | Aug 14, 2026 |
| Foresite Capital Management IV, LLC | 1.94M | 3.6% | no change | Aug 14, 2026 |
| Merck & Co., Inc. | 1.67M | 3.1% | no change | Aug 7, 2026 |
| Foresite Capital Management V, LLC | 1.32M | 2.4% | no change | Aug 14, 2026 |
| Vanguard | 1.23M | 2.3% | +99,751 | Aug 13, 2026 |
| Capital Group | 1.18M | 2.2% | +32,307 | Aug 12, 2026 |
| EcoR1 Capital, LLC | 733K | 1.4% | no change | Aug 14, 2026 |
| AllianceBernstein | 642K | 1.2% | −380K | Aug 14, 2026 |